$KNW
KNOW LABS, INC. Stock $knw

$knw Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000165495423006557 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$0.00	$0.00
YoY Change		-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.360M	$2.243M
YoY Change	-14.42%	54.86%
% of Gross Profit
Research & Development	$1.880M	$2.563M
YoY Change	47.7%	105.29%
% of Gross Profit
Depreciation & Amortization	$54.45K	$101.9K
YoY Change	-45.88%	33.42%
% of Gross Profit
Operating Expenses	$3.239M	$4.806M
YoY Change	7.07%	68.55%
Operating Profit	-$3.239M	-$4.806M
YoY Change	7.07%	69.07%
Interest Expense	$23.51K	$124.1K
YoY Change	-90.19%	-96.24%
% of Operating Profit
Other Income/Expense, Net	-$360.6K	-$124.1K
YoY Change	-1726.86%	-103.76%
Pretax Income	-$3.600M	-$4.930M
YoY Change	19.87%	-19.71%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.600M	-$4.930M
YoY Change	19.87%	-19.71%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.18	-$0.10
COMMON SHARES
Basic Shares Outstanding	48.49M shares	48.21M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.929M	$6.226M
YoY Change	-52.96%	-44.35%
Cash & Equivalents	$3.929M	$6.226M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$3.929M	$6.226M
YoY Change	-53.22%	-44.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$300.1K	$699.7K
YoY Change	-68.52%	-32.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.77K	$15.77K
YoY Change	14.52%	14.52%
Total Long-Term Assets	$507.6K	$913.8K
YoY Change	-58.71%	-32.64%
TOTAL ASSETS
Total Short-Term Assets	$3.929M	$6.226M
Total Long-Term Assets	$507.6K	$913.8K
Total Assets	$4.436M	$7.140M
YoY Change	-53.92%	-43.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$526.7K	$516.2K
YoY Change	29.91%	25.33%
Accrued Expenses	$416.2K	$434.3K
YoY Change	-22.06%	63.37%
Deferred Revenue
YoY Change
Short-Term Debt	$2.255M	$2.255M
YoY Change	0.0%	0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.721M	$3.734M
YoY Change	-19.3%	-30.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$0.00	$4.140K
YoY Change	-100.0%	-97.01%
Total Long-Term Liabilities	$0.00	$4.144K
YoY Change	-100.0%	-99.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.721M	$3.734M
Total Long-Term Liabilities	$0.00	$4.144K
Total Liabilities	$3.721M	$3.739M
YoY Change	-20.97%	-36.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$118.7M	-$110.2M
YoY Change	23.89%	18.67%
Common Stock	$52.36K	$48.21K
YoY Change	19.53%	10.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$715.4K	$3.401M
YoY Change
Total Liabilities & Shareholders Equity	$4.436M	$7.140M
YoY Change	-53.92%	-43.62%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$3.600M	-$4.930M
YoY Change	19.87%	-19.71%
Depreciation, Depletion And Amortization	$54.45K	$101.9K
YoY Change	-45.88%	33.42%
Cash From Operating Activities	-$2.635M	-$3.423M
YoY Change	-1.27%	-486.46%
INVESTING ACTIVITIES
Capital Expenditures	$38.94K	$31.01K
YoY Change	-334.58%	-107.02%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$38.94K	-$31.01K
YoY Change	134.58%	-92.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	377.2K	0.000
YoY Change	-352.7%	-100.0%
NET CHANGE
Cash From Operating Activities	-2.635M	-3.423M
Cash From Investing Activities	-38.94K	-31.01K
Cash From Financing Activities	377.2K	0.000
Net Change In Cash	-2.297M	-3.454M
YoY Change	-18.98%	-861.97%
FREE CASH FLOW
Cash From Operating Activities	-$2.635M	-$3.423M
Capital Expenditures	$38.94K	$31.01K
Free Cash Flow	-$2.674M	-$3.454M
YoY Change	0.82%	-360.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	knwn	Authorized Shares Of Capital Common Stock AuthorizedSharesOfCapitalCommonStock	200000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	knwn	Authorized Common Stock Increased AuthorizedCommonStockIncreased	200000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Proceeds From Sale Of Other Assets1 ProceedsFromSaleOfOtherAssets1	4360087	usd
CY2023Q1	knwn	Cash And Cash Equivalents CashAndCashEquivalents	6226029	usd
CY2023Q1	knwn	Net Working Capital NetWorkingCapital	4746689	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110150799	usd
	knwn	Proceeds Of Warrants Currently Outstanding ProceedsOfWarrantsCurrentlyOutstanding	7424679	usd
CY2023Q1	knwn	Right Of Use Assets RightOfUseAssets	198000	usd
	us-gaap	Lease Cost LeaseCost	146343	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2134459	usd
	us-gaap	Advertising Expense AdvertisingExpense	105045	usd
	us-gaap	Advertising Expense AdvertisingExpense	387434	usd
CY2023Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	6160227	usd
CY2022Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	11821931	usd
	knwn	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P13M
CY2022Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1510265	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26855	usd
CY2022Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26855	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	usd
CY2022Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	882848	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	677755	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	699740	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	862977	usd
	us-gaap	Depreciation Depreciation	205094	usd
	us-gaap	Depreciation Depreciation	118068	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	127232	usd
CY2023Q1	knwn	Total Remaining Payments TotalRemainingPayments	220351	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9561	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	210790	usd
CY2023Q1	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	90301	usd
CY2022Q3	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	86562	usd
	us-gaap	Equipment Expense EquipmentExpense	155702	usd
CY2023Q1	knwn	Convertible Notes Conversions ConvertibleNotesConversions	0	usd
CY2022Q3	knwn	Convertible Notes Conversions ConvertibleNotesConversions	-14209000	usd
CY2023Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2255066	usd
CY2022Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2255066	usd
	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	10074381	shares
	knwn	Received Of Warrant ReceivedOfWarrant	12500	usd
CY2022Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbers ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbers	21786313	shares
CY2022Q3	knwn	Outstanding At Begenning Of Period OutstandingAtBegenningOfPeriod	1.029
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	50000	shares
	knwn	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Prices ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrices	-0.250
	knwn	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	knwn	Exercisable At End Of Period ExercisableAtEndOfPeriod	21736313	shares
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	21736313	usd
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5580550	usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.766
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted	18807990	usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.359
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	28031	usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.300
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures	396000	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.815
CY2022	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted	12045330	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.376
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	36170	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.057
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	33644402	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.403
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted	5384116	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.250
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2344	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.611
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures	-15480581	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.568
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23545593	usd
	knwn	Exercise Stock Option Grants ExerciseStockOptionGrants	15019596	shares
	knwn	Intrinsic Value IntrinsicValue	142600	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1505405	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	636651	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001074828
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48207937	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48156062	shares
CY2023Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	usd
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18423245	shares
	knwn	Additional Common Shares Reserved AdditionalCommonSharesReserved	16124764	shares
CY2022Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	16464066	shares
CY2021Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbers ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbers	22564255	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2021Q3	knwn	Outstanding At Begenning Of Period OutstandingAtBegenningOfPeriod	0.998
CY2022Q3	knwn	Outstanding At End Of Period OutstandingAtEndOfPeriod	1.029
CY2023Q1	knwn	Convertible Notes Payable4 D ConvertibleNotesPayable4D	50000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Expiration Date StockRepurchaseProgramExpirationDate	2027-01-05
	us-gaap	Interest Expense Other InterestExpenseOther	194019	usd
CY2023Q1	knwn	Unrecognized Compensation Costs UnrecognizedCompensationCosts	1532729	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-30262
	dei	Entity Registrant Name EntityRegistrantName	KNOW LABS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0273142
	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 Union Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 810
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	48209	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	48158	usd
	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
	dei	Entity Address Country EntityAddressCountry	US
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98101
	dei	City Area Code CityAreaCode	206
	dei	Local Phone Number LocalPhoneNumber	903-1351
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	KNW
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48490685	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6226029	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12593692	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	6226029	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	12593692	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	699740	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	862977	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	15766	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	13767	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	198318	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	287930	usd
CY2023Q1	us-gaap	Assets Assets	7139853	usd
CY2022Q3	us-gaap	Assets Assets	13758366	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	516204	usd
CY2022Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	526968	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	434321	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	462940	usd
CY2023Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	322714	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	348264	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2255066	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2255066	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	206101	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	215397	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3734406	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3808635	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4144	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87118	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4144	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	87118	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	113501088	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	111209388	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110150799	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101397738	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3401303	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9862613	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7139853	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13758366	usd
CY2023Q1	us-gaap	Revenues Revenues	0	usd
CY2022Q1	us-gaap	Revenues Revenues	8687	usd
	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	4360087	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2563469	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1248707	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4306520	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2134459	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2242658	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1448227	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4147729	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2665174	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	0	usd
CY2022Q1	us-gaap	Selling Expense SellingExpense	154502	usd
	us-gaap	Selling Expense SellingExpense	0	usd
	us-gaap	Selling Expense SellingExpense	3272862	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	4806127	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2851436	usd
	us-gaap	Operating Expenses OperatingExpenses	8454249	usd
	us-gaap	Operating Expenses OperatingExpenses	8072495	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4806127	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2842749	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8454249	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3712408	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	124075	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	3297989	usd
	us-gaap	Interest Expense InterestExpense	298812	usd
	us-gaap	Interest Expense InterestExpense	7784949	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-124075	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3297989	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-298812	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7784949	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4930202	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6140738	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8753061	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11497357	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4930202	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6140738	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8753061	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11497357	usd
CY2023Q1	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.10
CY2022Q1	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.16
	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.18
	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.31
CY2023Q1	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	48207937	shares
CY2022Q1	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	37872406	shares
	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	48197581	shares
	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	36655905	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1242163	usd
CY2021Q4	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	204170	usd
CY2021Q4	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	766486	usd
CY2021Q4	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	2344	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-5356619	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3141456	usd
CY2022Q1	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	432481	usd
CY2022Q1	knwn	Conversion Of Debt Offering And Accrued Interest Note7 Amount ConversionOfDebtOfferingAndAccruedInterestNote7Amount	15345720	usd
CY2022Q1	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	9000	usd
CY2022Q1	knwn	Issuance Of Common Stock For Services Amount IssuanceOfCommonStockForServicesAmount	153000	usd
CY2022Q1	knwn	Issuance Of Warrant For Services IssuanceOfWarrantForServices	71220	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6140738	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	6729227	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9862613	usd
CY2022Q4	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	744640	usd
CY2022Q4	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	2343	usd
CY2022Q4	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	12500	usd
CY2022Q4	knwn	Expenses For Extension Of Notes And Warrants ExpensesForExtensionOfNotesAndWarrants	206994	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3822859	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7006231	usd
CY2023Q1	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	1182547	usd
CY2023Q1	knwn	Expenses For Extension Of Notes And Warrants ExpensesForExtensionOfNotesAndWarrants	142727	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4930202	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3401303	usd
	us-gaap	Profit Loss ProfitLoss	8753061	usd
	us-gaap	Profit Loss ProfitLoss	11497357	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	205094	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	118068	usd
	knwn	Issuance Of Common Stock For Services IssuanceOfCommonStockForServices	0	usd
	knwn	Issuance Of Common Stock For Services IssuanceOfCommonStockForServices	153000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	71220	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-1927187	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-636651	usd
	knwn	Right Of Use Net RightOfUseNet	-2658	usd
	knwn	Right Of Use Net RightOfUseNet	-11203	usd
	us-gaap	Interest Expense Foreign Deposits InterestExpenseForeignDeposits	349721	usd
	us-gaap	Interest Expense Foreign Deposits InterestExpenseForeignDeposits	0	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7272911	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1999	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	0	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	119210	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-64933	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2353901	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6340649	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1022019	usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	41857	usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	826956	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41857	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-826956	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2343	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11344	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	12500	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	766486	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14843	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	777830	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6367663	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1071145	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12593692	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12258218	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6226029	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11187073	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	0	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	14209000	usd
	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	0	usd
	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	1136720	usd
CY2023Q1	knwn	Authorized Shares Of Capital Stock AuthorizedSharesOfCapitalStock	205000000	shares
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4306520	usd
	knwn	Severance And Other Expenses SeveranceAndOtherExpenses	859000	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48207937	shares
CY2023Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	15019596	shares
CY2023Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	2255066	shares
	knwn	Convertible Debentures ConvertibleDebentures	2255066	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1552121	usd
CY2023Q1	knwn	Total Lease Liability TotalLeaseLiability	211000	usd
CY2022Q3	knwn	Total Lease Liability TotalLeaseLiability	302000	usd
CY2022Q3	knwn	Right Of Use Assets RightOfUseAssets	288000	usd
	us-gaap	Lease Cost LeaseCost	100103	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	93120	usd
CY2023Q1	knwn	Warrant Issued To Common Stock WarrantIssuedToCommonStock	50000	shares
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbe ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbe	21736313	shares
CY2023Q1	knwn	Outstanding At End Of Period OutstandingAtEndOfPeriod	1.031
	srt	Federal Funds Sold Average Yield FederalFundsSoldAverageYield	0	pure
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3M
	knwn	Expected Life Maximum ExpectedLifeMaximum	P5M
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	1.04	pure
	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.0296	pure
	knwn	Sharebased Compensation Arrangements By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementsBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	6522016	usd
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Unearned ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUnearned	1588333	shares
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.392
	knwn	Stock Option Grants StockOptionGrants	9609232	shares
CY2023Q1	knwn	Average Exercise Price AverageExercisePrice	1.611
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.161
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.565
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23964509	usd
CY2022	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures	2329267	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.618
CY2017Q2	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	3334	usd
	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	2986	usd
CY2021Q2	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	8697	usd
CY2021Q2	knwn	Lease Description LeaseDescription	increases by 3% annually. The lease expires on June 30, 2024. The lease can be extended for one additional three-year term
CY2021Q4	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	5000	usd
CY2022Q3	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	7000	usd
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	91500	usd
	us-gaap	Payments For Rent PaymentsForRent	28000	usd
CY2022Q4	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	2250	usd
CY2023Q1	knwn	Segment Revenues SegmentRevenues	0	usd
CY2023Q1	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-4806000	usd
CY2023Q1	knwn	Segment Asset SegmentAsset	7140000	usd
CY2022Q1	knwn	Segment Revenues SegmentRevenues	9	usd
CY2022Q1	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-2843000	usd
CY2022Q1	knwn	Segment Asset SegmentAsset	12663000	usd
	knwn	Segment Revenues SegmentRevenues	0	usd
	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-8454000	usd
	knwn	Segment Asset SegmentAsset	7140000	usd
	knwn	Segment Revenues SegmentRevenues	4361	usd
	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-3712000	usd
	knwn	Segment Asset SegmentAsset	12663000	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	2479344	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	8240647	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001654954-23-006557-index-headers.html	Edgar Link	pending
0001654954-23-006557-index.html	Edgar Link	pending
0001654954-23-006557.txt	Edgar Link	pending
0001654954-23-006557-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
know_10q.htm	Edgar Link	pending
know_10qimg1.jpg	Edgar Link	pending
know_ex108.htm	Edgar Link	pending
know_ex108img1.gif	Edgar Link	pending
know_ex311.htm	Edgar Link	pending
know_ex312.htm	Edgar Link	pending
know_ex321.htm	Edgar Link	pending
know_ex322.htm	Edgar Link	pending
knwn-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
knwn-20230331_cal.xml	Edgar Link	unprocessable
knwn-20230331_def.xml	Edgar Link	unprocessable
knwn-20230331_lab.xml	Edgar Link	unprocessable
knwn-20230331_pre.xml	Edgar Link	unprocessable
know_10q_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KNW
KNOW LABS, INC. Stock $knw

2023 Q2 Form 10-Q Financial Statement

#000165495423006557 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW KNOW LABS, INC. Stock $knw

2023 Q2 Form 10-Q Financial Statement

#000165495423006557 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW
KNOW LABS, INC. Stock $knw